# Potential Eligibility and Estimated Preventable Cardiovascular Disease Events From Inclisiran Treatment in the United States

> **NCT07214857** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 1385 (actual)

## Conditions studied

- Cardiovascular Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07214857
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-29
- **Primary completion:** 2024-10-09
- **Final completion:** 2024-10-09
- **Target enrollment:** 1385 (ACTUAL)
- **Last updated:** 2025-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07214857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07214857, "Potential Eligibility and Estimated Preventable Cardiovascular Disease Events From Inclisiran Treatment in the United States". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07214857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*